The effects of recombinant human soluble thrombomodulin treatment in patients with peritonitis with disseminated intravascular coagulation

被引：0
|
作者：
Hori, Naoto [1 ]
Takeda, Kenta [1 ]
Ide, Takeshi [1 ]
Ikedaq, Yuichiro [1 ]
Nishi, Shinichi [1 ]
机构：
[1] Hyogo Coll Med, Div Intens Care Unit, Kobe, Hyogo, Japan
来源：
BRITISH JOURNAL OF ANAESTHESIA | 2012年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [31] Effectiveness of Soluble Recombinant Human Thrombomodulin in Patients with Severe Acute Pancreatitis Complicated by Disseminated Intravascular Coagulation
    Yano, Takeshi
    Taniguchi, Masahiko
    Shirasaka, Tetsuro
    Tsuneyoshi, Isao
    TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, 2019, 47 (04) : 320 - 326
  • [32] PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT SOLUBLE THROMBOMODULIN IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WITH RENAL IMPAIRMENT
    Hayakawa, Mineji
    Yamamoto, Hiroshi
    Honma, Taeko
    Mukai, Nobutaka
    Higashiyama, Asumi
    Sugano, Masahiro
    Kubota, Nobuhiko
    Uegaki, Shinji
    Sawamura, Atsushi
    Gando, Satoshi
    SHOCK, 2012, 37 (06): : 569 - 573
  • [33] Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation (vol 173, pg 303, 2014)
    Shirahata, Akira
    Mimuro, Jun
    Takahashi, Hoyu
    Kitajima, Isao
    Tsuji, Hajime
    Eguchi, Yutaka
    Matsushita, Tadashi
    Kajiki, Masahiro
    Honda, Goichi
    Sakata, Yoichi
    EUROPEAN JOURNAL OF PEDIATRICS, 2014, 173 (10) : 1405 - 1406
  • [34] EFFECTS OF RECOMBINANT HUMAN THROMBOMODULIN ON SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
    Uemura, Tatsuki
    Hiruma, Hiromitsu
    Hagiwara, Akiyoshi
    Makinouchi, Ryuichiro
    Matsuda, Wataru
    Kimura, Akio
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [35] Evaluation of recombinant thrombomodulin treatment for septic disseminated intravascular coagulation
    Yamauchi, Hiroki
    Miura, Masanao
    Nakamura, Fujio
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [36] Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
    Yuki Asai
    Takanori Yamamoto
    Daisuke Kito
    Kazuya Ichikawa
    Yasuharu Abe
    Journal of Pharmaceutical Health Care and Sciences, 6
  • [37] Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
    Asai, Yuki
    Yamamoto, Takanori
    Kito, Daisuke
    Ichikawa, Kazuya
    Abe, Yasuharu
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2020, 6 (01)
  • [38] Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation
    Maruyama, I
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 718 - 721
  • [39] Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation
    Ikezoe, Takayuki
    Takeuchi, Asako
    Kim, Tsukie
    Akabuki, Kazuki
    Sakai, Mizu
    Taniguchi, Ayuko
    Togitani, Tazuto
    Yokoyama, Akihito
    BLOOD, 2012, 120 (21)
  • [40] POPULATION PHARMACOKINETICS OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN ALFA IN PEDIATRIC HEMATOLOGIC MALIGNANCY PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION.
    Takeuchi, M.
    Tanoshima, R.
    Sasaki, K.
    Kato, H.
    Yanagimachi, M.
    Ito, S.
    Yokota, S.
    Miyagawa, N.
    Sarashina, T.
    Yokosuka, T.
    Ito, S.
    Goto, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S6 - S6
12345